Company / Cost of Revenue
Fortress Biotech, Inc. Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$20.9M
FY2025
5-year range
$14.6M / $32.1M
FY2021-FY2025
Trend
-8.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cost of Revenue has declined for 3 consecutive years, from $32M in FY2022 to $21M in FY2025.
Based on SEC 10-K filings.
$21M in FY2025 with a 5-year CAGR of +14.7%.
Improved from $31M to $21M over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -13.3%
- 5-Year CAGR
- +14.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- Fortress Biotech, Inc.'s cost of revenue has declined for 3 consecutive years.
- 5-year CAGR of +14.7%, indicating consistent growth.
- In FY2025, cost of revenue decreased 8.8% year-over-year.
- Peak cost of revenue was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.9M | -8.8% |
| FY2024 | $22.9M | -25.6% |
| FY2023 | $30.8M | -4.1% |
| FY2022 | $32.1M | +119.8% |
| FY2021 | $14.6M | +38.6% |
| FY2020 | $10.5M | +72.0% |
| FY2019 | $6.1M | +67.4% |
| FY2018 | $3.7M | - |
| FY2017 | $0 | - |
| FY2016 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026